HomeProductsBuilding BlocksHeterocyclic ScaffoldsAliphatic HeterocyclesZenuzolac
Chemical structure of CAS 6501-72-0

Zenuzolac

CAS No.6501-72-0
MDL No.MFCD08696167
MFC11H11NO3
MW205.21
InChI KeyMUFJHYRCIHHATF-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.6501-72-0
Product NameZenuzolac

Associated Conditions

rheumatoid arthritis
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

VGX-1027 modulates genes involved in lipopolysaccharide-induced Toll-like receptor 4 activation and in a murine model of systemic lupus erythematosus.

Immunology • Vol. 142, Issue 4 • 2014
PMID: 24527796PMC: PMC4107669DOI: 10.1111/imm.12267

Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology • Vol. 35, Issue 4 • 2010
PMID: 20032969PMC: PMC2827881DOI: 10.1038/npp.2009.201

Effects of the immunomodulator, VGX-1027, in endotoxin-induced uveitis in Lewis rats.

British journal of pharmacology • Vol. 155, Issue 5 • 2008
PMID: 18776919PMC: PMC2584921DOI: 10.1038/bjp.2008.315

Documentation

Similar Products